You are viewing the comprehensive archive for articles tagged with "biotech". Our editorial team provides essential coverage, in-depth analysis, and real-time market data across all critical topics impacting the global economy. This section compiles the most relevant news, research, and expert commentary to help you navigate the trends and forces shaping the financial world. Stay informed with MarketSpeaker to ensure your knowledge is current and comprehensive.
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
Novartis has agreed to acquire immunology biotech Excellergy for $2 billion, marking its second major deal in a week. The move strengthens its pipeline in next-generation allergy treatments.
Leap Therapeutics shares jump 170% after rebranding to Cypherpunk and investing $50M in Zcash, marking a major shift toward digital asset strategy.
The Chan Zuckerberg Biohub, founded by Mark Zuckerberg and Priscilla Chan, announced a new initiative merging artificial intelligence, biology, and computing to accelerate breakthroughs in health and disease research.
Molecular-diagnostics startup BillionToOne raised $273 million in an oversubscribed IPO, with shares jumping 67% at debut and valuing the company at around $4.4 billion.